Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET

J Nucl Med. 2009 May;50(5):814-7. doi: 10.2967/jnumed.108.058131. Epub 2009 Apr 16.

Abstract

We measured the whole-body distribution of intravenously injected (11)C-N-propylnorapomorphine ((11)C-NPA), a dopamine agonist PET tracer, in human subjects and determined the resulting absorbed radiation doses.

Methods: Six subjects (3 women, 3 men) were injected with (11)C-NPA (nominal dose, 370 MBq). A total of 9 consecutive whole-body PET scans were obtained for each subject. In addition, time-activity curves for 12 organs were determined, and residence times were computed for each subject. Dosimetry was determined for the various body organs and the whole body.

Results: The average NPA whole-body radiation dose was 3.17 x 10(-3) mSv per MBq of injected (11)C-NPA. The organ receiving the highest dose was the gallbladder wall, with an average of 2.81 x 10(-2) mSv.MBq(-1).

Conclusion: On the basis of averaged dosimetry results, an administration of less than 1,780 MBq (<48 mCi) of (11)C-NPA yields an organ dose of under 50 mSv (5 rem) to all organs.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Apomorphine / administration & dosage
  • Apomorphine / analogs & derivatives*
  • Apomorphine / pharmacokinetics
  • Body Burden
  • Carbon Radioisotopes / administration & dosage
  • Carbon Radioisotopes / pharmacokinetics
  • Dopamine D2 Receptor Antagonists*
  • Female
  • Humans
  • Male
  • Metabolic Clearance Rate
  • Organ Specificity
  • Positron-Emission Tomography / methods*
  • Radiometry
  • Radiopharmaceuticals / administration & dosage
  • Radiopharmaceuticals / pharmacokinetics
  • Receptors, Dopamine D2 / metabolism
  • Receptors, Dopamine D3 / antagonists & inhibitors*
  • Receptors, Dopamine D3 / metabolism
  • Tissue Distribution
  • Whole-Body Counting / methods*

Substances

  • Carbon Radioisotopes
  • Dopamine D2 Receptor Antagonists
  • Radiopharmaceuticals
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3
  • N-n-propylnorapomorphine
  • Apomorphine